-->

Curaleaf Holdings Stock EBITDA

CURLF Stock  USD 1.44  0.04  2.70%   
Fundamental analysis of Curaleaf Holdings allows traders to better anticipate movements in Curaleaf Holdings' stock price by examining its financial health and performance throughout various phases of its business cycle.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Curaleaf Holdings OTC Stock EBITDA Analysis

Curaleaf Holdings' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Curaleaf Holdings EBITDA

    
  287.7 M  
Most of Curaleaf Holdings' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Curaleaf Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Curaleaf Holdings reported earnings before interest,tax, depreciation and amortization of 287.7 M. This is 67.21% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 92.62% higher than that of the company.

Curaleaf EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Curaleaf Holdings' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Curaleaf Holdings could also be used in its relative valuation, which is a method of valuing Curaleaf Holdings by comparing valuation metrics of similar companies.
Curaleaf Holdings is currently under evaluation in ebitda category among its peers.

Curaleaf Fundamentals

About Curaleaf Holdings Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Curaleaf Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curaleaf Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curaleaf Holdings based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Curaleaf OTC Stock

Curaleaf Holdings financial ratios help investors to determine whether Curaleaf OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Curaleaf with respect to the benefits of owning Curaleaf Holdings security.